title: Serum selenium predicts outcome in HIV infection.
authors.forename: J
authors.initials: J
authors.lastname: Constans
authors.forename: J L
authors.initials: JL
authors.lastname: Pellegrin
authors.forename: C
authors.initials: C
authors.lastname: Sergeant
authors.forename: M
authors.initials: M
authors.lastname: Simonoff
authors.forename: I
authors.initials: I
authors.lastname: Pellegrin
authors.forename: H
authors.initials: H
authors.lastname: Fleury
authors.forename: B
authors.initials: B
authors.lastname: Leng
authors.forename: C
authors.initials: C
authors.lastname: Conri
mesh_terms: D000328:Adult; D018791:CD4 Lymphocyte Count; D005260:Female; D016655:HIV Core Protein p24 / Q000032:analysis; D006679:HIV Seropositivity / Q000097:blood* / Q000503:physiopathology; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D008297:Male; D011379:Prognosis; D012643:Selenium / Q000097:blood*; D013052:Spectrometry, X-Ray Emission; D001613:beta 2-Microglobulin / Q000032:analysis
chemical_list: D016655:HIV Core Protein p24; D001613:beta 2-Microglobulin; D012643:Selenium